GSA Capital Partners’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,681
| Closed | -$904K | – | 2034 |
|
|
2022
Q3 | $904K | Buy |
3,681
+1,714
| +87% | +$421K | 0.12% | 207 |
|
|
2022
Q2 | $487K | Buy |
+1,967
| New | +$487K | 0.07% | 521 |
|
|
2021
Q4 | – | Sell |
-3,185
| Closed | -$1.04M | – | 1937 |
|
|
2021
Q3 | $1.04M | Buy |
+3,185
| New | +$1.04M | 0.11% | 300 |
|
|
2020
Q2 | – | Sell |
-2,062
| Closed | -$299K | – | 1254 |
|
|
2020
Q1 | $299K | Sell |
2,062
-4,899
| -70% | -$710K | 0.08% | 493 |
|
|
2019
Q4 | $1.19M | Buy |
6,961
+5,169
| +288% | +$881K | 0.14% | 138 |
|
|
2019
Q3 | $319K | Sell |
1,792
-1,134
| -39% | -$202K | 0.04% | 846 |
|
|
2019
Q2 | $762K | Sell |
2,926
-9,995
| -77% | -$2.6M | 0.09% | 399 |
|
|
2019
Q1 | $3.69M | Buy |
+12,921
| New | +$3.69M | 0.37% | 13 |
|
|
2017
Q2 | – | Sell |
-2,167
| Closed | -$271K | – | 2030 |
|
|
2017
Q1 | $271K | Sell |
2,167
-7,995
| -79% | -$1,000K | 0.01% | 1432 |
|
|
2016
Q4 | $1.15M | Sell |
10,162
-599
| -6% | -$67.5K | 0.07% | 491 |
|
|
2016
Q3 | $1.38M | Sell |
10,761
-7,290
| -40% | -$938K | 0.07% | 422 |
|
|
2016
Q2 | $1.97M | Buy |
18,051
+10,289
| +133% | +$1.12M | 0.11% | 248 |
|
|
2016
Q1 | $736K | Buy |
7,762
+2,600
| +50% | +$247K | 0.05% | 738 |
|
|
2015
Q4 | $466K | Sell |
5,162
-11,251
| -69% | -$1.02M | 0.02% | 1203 |
|
|
2015
Q3 | $1.52M | Sell |
16,413
-860
| -5% | -$79.7K | 0.07% | 391 |
|
|
2015
Q2 | $1.14M | Buy |
17,273
+2,257
| +15% | +$148K | 0.04% | 780 |
|
|
2015
Q1 | $1.08M | Buy |
+15,016
| New | +$1.08M | 0.04% | 807 |
|
|
2014
Q4 | – | Sell |
-9,216
| Closed | -$229K | – | 1957 |
|
|
2014
Q3 | $229K | Buy |
+9,216
| New | +$229K | 0.01% | 1439 |
|
|
2014
Q2 | – | Sell |
-21,116
| Closed | -$550K | – | 2005 |
|
|
2014
Q1 | $550K | Sell |
21,116
-2,914
| -12% | -$75.9K | 0.04% | 714 |
|
|
2013
Q4 | $643K | Buy |
24,030
+7,014
| +41% | +$188K | 0.05% | 638 |
|
|
2013
Q3 | $324K | Buy |
+17,016
| New | +$324K | 0.03% | 1086 |
|